---
title: "002412.SZ (002412.SZ) — 相關新聞"
type: "Symbol"
locale: "zh-HK"
url: "https://longbridge.com/zh-HK/quote/002412.SZ/news.md"
symbol: "002412.SZ"
name: "002412.SZ"
parent: "https://longbridge.com/zh-HK/quote/002412.SZ.md"
datetime: "2026-03-11T23:25:12.552Z"
locales:
  - [en](https://longbridge.com/en/quote/002412.SZ/news.md)
  - [zh-CN](https://longbridge.com/zh-CN/quote/002412.SZ/news.md)
  - [zh-HK](https://longbridge.com/zh-HK/quote/002412.SZ/news.md)
---

> 支持的語言: [English](https://longbridge.com/en/quote/002412.SZ/news.md) | [简体中文](https://longbridge.com/zh-CN/quote/002412.SZ/news.md)


# 002412.SZ (002412.SZ) — 相關新聞

### [Hanfang Pharmaceutical's IPO in Hong Kong faces "bottlenecks" in revenue and net profit growth, with research and development expenses far lower than marketing expenses](https://longbridge.com/zh-HK/news/278337598.md)
*2026-03-09T06:10:53.000Z*
> Hanfang Pharmaceutical has released its prospectus for its IPO on the Hong Kong Stock Exchange, indicating that its reve

### [New Stock News | HanFang Pharmaceutical submits application to Hong Kong Stock Exchange](https://longbridge.com/zh-HK/news/276884578.md)
*2026-02-25T12:15:07.000Z*
> According to the Hong Kong Stock Exchange's disclosure on February 25, Shandong Hanfang Pharmaceutical Co., Ltd. (abbrev

### [](https://longbridge.com/zh-HK/news/275390610.md)
*2026-02-10T02:16:45.000Z*
> The A-share innovative drug sector fluctuated and surged, with WBDE and HISOAR both hitting the daily limit, while Salub

### [Lin Yuan takes action! Policies bring warmth! The A-share "drinking and medicine" market begins!](https://longbridge.com/zh-HK/news/275127717.md)
*2026-02-06T12:39:59.000Z*
> Recently, the liquor and traditional Chinese medicine sectors have rebounded under favorable policies and market capital

### [A-share midday review: Stock indices rebounded from the bottom and turned positive collectively, with the ChiNext rising 0.65% in half a day. The chemical concept surged, while non-ferrous metals and optical communication concept stocks rebounded, and the consumer sector declined](https://longbridge.com/zh-HK/news/275069033.md)
*2026-02-06T03:57:17.000Z*
> The A-share market performed well on February 6, with the three major indices quickly rebounding after a low opening. Th

### [February 6th Midday Review: ChiNext opened lower but rose to gain 0.65%, with chemical and robotics concept stocks collectively strengthening](https://longbridge.com/zh-HK/news/275067184.md)
*2026-02-06T03:30:53.000Z*
> The market opened lower in the morning but rose throughout the day, with all three major indices turning positive. Tradi

### [Eight departments issued a heavy document! The Chinese medicine sector exploded, Zhendong Pharmacy surged over 19%, TY PHAR. and Hansen Pharmaceutical hit the daily limit](https://longbridge.com/zh-HK/news/275061561.md)
*2026-02-06T02:27:17.000Z*
> The Chinese medicine sector surged against the trend in the morning session, with Zhendong Pharmacy rising over 19%, and

### [Hansen Pharmaceutical: The net profit for the third quarter was 13.9868 million yuan, a year-on-year decrease of 53.78%](https://longbridge.com/zh-HK/news/262866726.md)
*2025-10-27T10:12:35.000Z*
> Hansen Pharmaceutical announced that its revenue for the third quarter was 232 million yuan, an increase of 8.62% year-o

### [Hansen Pharmaceutical released its performance for the first half of the year, with a net profit attributable to the parent company of 68.5384 million yuan, a decrease of 31.80%](https://longbridge.com/zh-HK/news/254418220.md)
*2025-08-25T10:44:02.000Z*
> Hansen Pharmaceutical released its semi-annual report for 2025, with operating revenue of 509 million yuan, a year-on-ye

### [](https://longbridge.com/zh-HK/news/254352391.md)
*2025-08-25T01:52:00.000Z*
> The A-share traditional Chinese medicine sector rapidly surged, with Xintian Pharma hitting the limit up, and YIBAI PHAR